Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004497 · ClinicalTrials.gov registry record · Phase 3
Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
A Phase 3 study, sponsored by United Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00004497: Completed Phase 3 study, sponsored by United Therapeutics.
NCT00004497 is a Phase 3 study that has completed, run by United Therapeutics. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004497, a Phase 3 study, has completed, sponsored by United Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
OBJECTIVES: I. Determine the safety and efficacy of UT-15 in patients with severe symptomatic primary pulmonary hypertension.
Interventions
- DRUG UT-15
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-10 |
| Est. Completion | 2000-09 |
| Phase | Phase 3 |
What the finished NCT00004497 record still lists
NCT00004497 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which UT-15 is the first listed.
NCT00004497 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004497 about?
NCT00004497 is a clinical study titled "Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension". OBJECTIVES: I. Determine the safety and efficacy of UT-15 in patients with severe symptomatic primary pulmonary hypertension.
What is the current status of trial NCT00004497?
This trial is currently completed. It is a Phase 3 study. The study started on 1998-10. Estimated completion is 2000-09.
What interventions are being tested in trial NCT00004497?
The interventions under investigation include: UT-15 (DRUG).
Who is sponsoring clinical trial NCT00004497?
This trial is sponsored by United Therapeutics, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia